Beatriz Fontana-Garcia

Granada, AN 18016, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Serum Periostin as a Complementary Biomarker of Frailty in Type 2 Diabetes: A Pilot Study Using the FRAIL Scale.

Serum Periostin as a Complementary Biomarker of Frailty in Type 2 Diabetes: A Pilot Study Using the FRAIL Scale.

Journal: International journal of molecular sciences

Published: July 10, 2026

Osteoglycin and Sclerostin Imbalance in Hypophosphatasia: Bone-Derived Markers of Mineralization and Systemic Involvement.

Osteoglycin and Sclerostin Imbalance in Hypophosphatasia: Bone-Derived Markers of Mineralization and Systemic Involvement.

Journal: International journal of molecular sciences

Published: June 26, 2026

Tissue nonspecific and intestinal alkaline phosphatase crosstalk: a missing link in hypophosphatasia pathophysiology?

Tissue nonspecific and intestinal alkaline phosphatase crosstalk: a missing link in hypophosphatasia pathophysiology?

Journal: Journal of translational medicine

Published: November 04, 2025

Factors Related to Decline of Renal Function in Patients with Chronic Hypoparathyroidism.

Factors Related to Decline of Renal Function in Patients with Chronic Hypoparathyroidism.

Journal: Journal of clinical medicine

Published: June 23, 2025

Alkaline Phosphatase as a Potential Biomarker of Muscle Function: A Pilot Study in Patients with Hypophosphatasia.

Alkaline Phosphatase as a Potential Biomarker of Muscle Function: A Pilot Study in Patients with Hypophosphatasia.

Journal: International journal of molecular sciences

Published: May 07, 2025

Impact of 24-week concurrent training on bone parameters and plasma levels of osteoglycin and sclerostin in young, sedentary adults: secondary analyses from the ACTIBATE randomized controlled trial.

Impact of 24-week concurrent training on bone parameters and plasma levels of osteoglycin and sclerostin in young, sedentary adults: secondary analyses from the ACTIBATE randomized controlled trial.

Journal: European journal of endocrinology

Published: January 09, 2025

Movement Behaviors and Bone Biomarkers in Young Pediatric Cancer Survivors: A Cross-Sectional Analysis of the iBoneFIT Project.

Movement Behaviors and Bone Biomarkers in Young Pediatric Cancer Survivors: A Cross-Sectional Analysis of the iBoneFIT Project.

Journal: Nutrients

Published: October 04, 2024

Bone proteins are associated with cardiovascular risk according to the SCORE2-Diabetes algorithm.

Bone proteins are associated with cardiovascular risk according to the SCORE2-Diabetes algorithm.

Journal: Cardiovascular diabetology

Published: July 11, 2024

Non-Classical Effects of FGF23: Molecular and Clinical Features.

Non-Classical Effects of FGF23: Molecular and Clinical Features.

Journal: International journal of molecular sciences

Published: April 08, 2024

Systemic effects of hypophosphatasia characterization of two novel variants in the ALPL gene.

Systemic effects of hypophosphatasia characterization of two novel variants in the ALPL gene.

Journal: Frontiers in endocrinology

Published: October 12, 2023

Exploring the role of osteoglycin in type 2 diabetes: implications for insulin resistance and vascular pathophysiology.

Exploring the role of osteoglycin in type 2 diabetes: implications for insulin resistance and vascular pathophysiology.

Journal: American journal of physiology. Endocrinology and metabolism

Published: October 11, 2023

Cardioprotective function of sclerostin by reducing calcium deposition, proliferation, and apoptosis in human vascular smooth muscle cells.

Cardioprotective function of sclerostin by reducing calcium deposition, proliferation, and apoptosis in human vascular smooth muscle cells.

Journal: Cardiovascular diabetology

Published: July 05, 2023

Showing 1-12 of 48

Last Updated: 09/26/2026